A new prescription eye drop called Vuity is offering a fresh solution for people struggling with presbyopia, a common ...

Vuity offers a promising new approach to managing the effects of presbyopia, providing a convenient alternative for those looking to reduce their reliance on reading glasses. While not a cure, Vuity ...

AbbVie has ended speculation about what it will charge for its newly-approved Vuity therapy for presbyopia, a sight condition characterised by difficulty in focusing on near objects. The company ...

The approval has been granted to Vuity (formerly AGN-190584), a once-daily eyedrop formulation of muscarinic cholinergic agonist pilocarpine developed by AbbVie's Allergen unit that is now an ...

In 2022, a similar formulation was introduced in the US under the brand name Vuity, after receiving approval from the US Food and Drug Administration (US FDA). Vuity is currently the only FDA ...